Topic
Biomarkers
22 Podcasts • 1 Case • 2 Courses on BackTable
Episode # 336 • 15 Oct 2026
Biomarkers in Treatment Intensification for Prostate Cancer
Same risk group, very different benefit. Can biomarkers help identify who needs treatment intensification in prostate cancer? On this episode of BackTable Urology, Dr. Ruchika Talwar and Dr. Angela Jia, a radiation oncologist at University Hospitals Cleveland Medical Center, break down the difference between prognostic and predictive biomarkers and how genomic testing is informing the way clinicians counsel patients. They review trial data suggesting that men with a low genomic score may gain little from adding hormone therapy, along with early prospective evidence that the luminal B subtype may help identify who benefits most from intensification.
This podcast is supported by
More on Biomarkers
Loading recent podcasts…
Urology # 336
Oct 14, 2026
with Dr. Angela Jia, Dr. Ruchika Talwar
Same risk group, very different benefit. Can biomarkers help identify who needs treatment intensification in prostate...
Urology # 314
Jul 6, 2026
with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...
1,000+ listens
Urology # 307
Jun 8, 2026
with Dr. Tanya Dorff, Dr. Evan Yu, Dr. Alan Tan
Can you really treat prostate cancer effectively without knowing the genetics? In this episode of BackTable Urology,...
1,100+ listens
Tumor Board # 58
May 4, 2026
with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...
Women's Health # 133
Sep 7, 2026
with Dr. Hugh Taylor, Dr. Nicole Faulkner
Advances in endometriosis research are reshaping how clinicians diagnose, understand, and treat this complex...
Tumor Board # 70
Jun 29, 2026
with Dr. Chih-Yi Liao, Dr. Xavier Keutgen, Dr. Lingling Du
How do you unravel the complexity of diagnosing and managing neuroendocrine tumors, where every case demands a tailored...
CardioNerds # 452
May 31, 2026
with Dr. Stavros Konstantinides, Dr. Billy Joe Mullinax, Dr. Dinu Balanescu, Dr. Jane Ehret
CardioNerds discuss risk stratification in acute pulmonary embolism with Dr. Stavros Konstantinides, Chair of the 2019...
Urology # 301
May 4, 2026
with Dr. Udit Singhal, Dr. Ruchika Talwar
Are biomarkers the missing link in personalized prostate cancer care? What is the practical role of biomarkers across...
1,600+ listens
Tumor Board Case
Jun 29, 2026
with Dr. Chih-Yi Liao, Dr. Xavier Keutgen and Dr. Lingling Du
Urology Course
3 hours, 28 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.